Clinical data showed that CD16+ monocytes were increased in various inflammatory conditions, such as coronary artery disease (42), liver fibrosis (43), NAFLD (44), aging (40), and systemic sclerosis (45). Here, FCGR3A is linked to Hepatic fibrosis.